AMOXICILLIN Drug Patent Profile
✉ Email this page to a colleague
When do Amoxicillin patents expire, and when can generic versions of Amoxicillin launch?
Amoxicillin is a drug marketed by Aurobindo, Chartwell, Hikma Pharms, Labs Atral, Micro Labs, Mylan, Sandoz, Strides Pharma, Sun Pharm Inds Ltd, Teva, Aurobindo Pharma Ltd, Chartwell Rx, Dava Pharms Inc, Hikma, Wockhardt Bio Ag, Apothecon, Aurobindo Pharma, Deva Holding As, Micro Labs Ltd India, Sandoz Inc, Apotex Inc, and Teva Pharms Usa. and is included in eighty-five NDAs.
The generic ingredient in AMOXICILLIN is amoxicillin; clavulanate potassium. There are forty-six drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the amoxicillin; clavulanate potassium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Amoxicillin
A generic version of AMOXICILLIN was approved as amoxicillin; clavulanate potassium by SANDOZ on March 14th, 2002.
Summary for AMOXICILLIN
US Patents: | 0 |
Applicants: | 22 |
NDAs: | 85 |
Finished Product Suppliers / Packagers: | 34 |
Raw Ingredient (Bulk) Api Vendors: | 68 |
Clinical Trials: | 561 |
Patent Applications: | 1,017 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for AMOXICILLIN |
Drug Sales Revenues: | Drug sales revenues for AMOXICILLIN |
What excipients (inactive ingredients) are in AMOXICILLIN? | AMOXICILLIN excipients list |
DailyMed Link: | AMOXICILLIN at DailyMed |
Recent Clinical Trials for AMOXICILLIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Missouri-Columbia | Phase 4 |
Abdul El-Rabbany | Phase 4 |
TenNor Therapeutics (Suzhou) Limited | Phase 3 |
Pharmacology for AMOXICILLIN
Drug Class | Penicillin-class Antibacterial |